Adem Alemdar

Dr. Adem Alemdar

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2022 in The Breast
Verified
Journal Article
Open access
ABAtıl Bışgın
Atıl Bışgın
SSSebnem Ozemri Sag
Sebnem Ozemri Sag
MDMuhammet E. Dogan
Muhammet E. Dogan
MYMahmut S. Yildirim
Mahmut S. Yildirim
AGAydeniz Aydin Gumus
Aydeniz Aydin Gumus
STSEHIME TEMEL
SEHIME TEMEL
BRCA1/2 mutations play a significant role in cancer pathogenesis and predisposition particularly in breast, ovarian and prostate cancers. Thus, germline analysis of BRCA1 and BRCA2 is essential for clinical management strategies aiming at the identification of recurrent and novel mutations that could be used as a first screening approach. We analyzed germline variants of BRCA1/2 genes for 2168 individuals who had cancer diagnosis or high risk assessment due to BRCAs related cancers, referred to 10 health care centers distributed across 7 regions covering the Turkish landscape. Overall, 68 and 157 distinct mutations were identified in BRCA1 and BRCA2, respectively. Twenty-two novel variants were reported from both genes while BRCA2 showed higher mutational heterogeneity. We herein report the collective data as BRCA Turkish consortium that confirm the molecular heterogeneity in BRCAs among Turkish population, and also as the first study presenting the both geographical, demographical and gene based landscape of all recurrent and novel mutations which some might be a founder effect in comparison to global databases. This wider perspective leads to the most accurate variant interpretations which pave the way for the more precise and efficient management affecting the clinical and molecular aspects.

20 October 2020 in Türk Tarım ve Doğa Bilimleri Dergisi
Verified
Journal Article
Closed access
NANurten Aydoğdu
Nurten Aydoğdu
AAAdem Alemdar
Adem Alemdar
HKHatice Torcu Koç Koç
Hatice Torcu Koç Koç
ZEZeliha Erdoğan
Zeliha Erdoğan
Bu çalışmada; Rhodeus amarus’ un Ekim 2018 – Aralık 2018 tarihleri arasındaki helmint faunasının belirlenmesi amaçlanmıştır. Çalışma sonucunda; 51 adet R. amarus bireyinin 18’ nin bir ya da daha fazla parazit türü ile enfekte olduğu bulunmuştur. Konak balıkta toplam 3 adet ektoparazitik helmint türü tanımlanmış olup, üç farklı türe ait 34 parazit bireyine rastlanılmıştır. Bu parazitlerden Monogenea’ dan Dactylogyrus bicornis Malewitzkaja, 1941 (%17,6; 2 parazit/balık); Paradiplozoon homoion ( Bychowsky and Nagibina, 1959) (%11,7; 1,3 parazit/balık) konak balığın solungaçlarında, Digenea’ dan Clinostomum complanatum metaserkeri (Rhudolphi, 819) (%13,7; 1,1 parazit/balık) konak balığın solungaç boşluğunda kaydedilebilmiştir. Bu çalışmada, D. bicornis 9 balıkta toplam 18 adet bulunmuş olup, en yaygın parazit türü olarak. kaydedilmiştir. Parazit türlerine ait enfeksiyon yüzdeleri ile minimum, maksimum ve ortalama enfeksiyon yoğunlukları değerlendirilmiştir. Diğer taraftan, bu çalışma Susurluk Havzası balık faunasında yer alan R. amarus’ un helmint parazitleri üzerine yapılan ilk çalışmadır. Saptanan türlerden, P. homoion ise Türkiye’deki acı balıklarda ilk kez bu çalışma ile bildirilmiştir. Ayrıca bu çalışmada konak balıkta kaydedilen türlerden her biri Susurluk Çayı için yeni kayıttır ve Anadolu’ daki dağılımlarına yeni bir lokalite olarak eklenmiştir.

19 July 2024 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
LALamiya Aliyeva
Lamiya Aliyeva
YÖYasemin Denkboy Öngen
Yasemin Denkboy Öngen
EEErdal Eren
Erdal Eren
MSMehmet B. Sarisozen
Mehmet B. Sarisozen
AAAdem Alemdar
Adem Alemdar
SSSebnem Ozemri Sag
Sebnem Ozemri Sag

3 July 2023 in European Journal of Breast Health
Verified
Journal Article
Closed access
IBIbrahim Boga
Ibrahim Boga
SSSebnem Ozemri Sag
Sebnem Ozemri Sag
NDNilgun Duman
Nilgun Duman
SOSevda Yesim Ozdemir
Sevda Yesim Ozdemir
Mahmut Cerkez ErgorenMahmut Cerkez Ergoren
Mahmut Cerkez Ergoren
STSEHIME TEMEL
SEHIME TEMEL
Breast cancer (BC) is the most common cancer type in women and may be inherited, mostly in an autosomal dominant pattern. The clinical diagnosis of BC relies on the published diagnostic criteria, and analysis of two genes, BRCA1 and BRCA2, which are strongly associated with BC, are included in these criteria. The aim of this study was to compare BC index cases with non-BC individuals in terms of genotype and diagnostic features to investigate the genotype/demographic information association. Mutational analyses for the BRCA1/BRCA2 genes was performed in 2475 individuals between 2013-2022 from collaborative centers across Turkey, of whom 1444 with BC were designated as index cases. Overall, mutations were identified in 17% (421/2475), while the percentage of mutation carriers in cases of BC was similar, 16.6% (239/1444). BRCA1/BRCA2 gene mutations were detected in 17.8% (131/737) of familial cases and 12% (78/549) of sporadic cases. Mutations in BRCA1 were found in 4.9%, whereas 12% were in BRCA2 (p<0.05). Meta-analyses were performed to compare these results with other studies of Mediterranean-region populations. Patients with BRCA2 mutations were significantly more common than those with BRCA1 mutations. In sporadic cases, there was a lower proportion with BRCA1/BRCA2 variants, as expected, and these results were consistent with the data of Mediterranean-region populations. However, the present study, because of the large sample size, revealed more robust findings than previous studies. These findings may be helpful in facilitating the clinical management of BC for both familial and non-familial cases.

27 April 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Aya Badeea IsmailAya Badeea Ismail
Aya Badeea Ismail
Mehmet Sait DündarMehmet Sait Dündar
Mehmet Sait Dündar
COCemre Ornek
Cemre Ornek
Mahmut Cerkez ErgorenMahmut Cerkez Ergoren
Mahmut Cerkez Ergoren
AAAdem Alemdar
Adem Alemdar
STSEHIME TEMEL
SEHIME TEMEL
Alzheimer’s disease (AD) is a major global health challenge, especially among individuals aged 65 or older. According to population health studies, Turkey has the highest AD prevalence in the Middle East and Europe. To accurately determine the frequencies of common and rare APOE single nucleotide polymorphisms (SNPs) in the Turkish population residing in the Marmara Region, we conducted a retrospective study analyzing APOE variants in 588 individuals referred to the Bursa Uludag University Genetic Diseases Evaluation Center. Molecular genotyping, clinical exome sequencing, bioinformatics analysis, and statistical evaluation were employed to identify APOE polymorphisms and assess their distribution. The study revealed the frequencies of APOE alleles as follows: ε4 at 9.94%, ε2 at 9.18%, and ε3 at 80.68%. The gender-based analysis in our study uncovered a tendency for females to exhibit a higher prevalence of mutant genotypes across various SNPs. The most prevalent haplotype observed was ε3/ε3, while rare APOE SNPs were also identified. These findings align with global observations, underscoring the significance of genetic diversity and gender-specific characteristics in comprehending health disparities and formulating preventive strategies.

11 March 2021 in SDÜ Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
SSSebnem Ozemri Sag
Sebnem Ozemri Sag
AAAdem Alemdar
Adem Alemdar
LALamiya Ali̇yeva
Lamiya Ali̇yeva
NKNiyazi Kaya
Niyazi Kaya
STSEHIME TEMEL
SEHIME TEMEL
Objective We aimed to evaluate frequency and distribution MEFV gene mutation variants in patients with presumptive diagnosis of Familial Mediterranean Fever (FMF). Material and Methods Patients who had undergone FMF targeted mutation analysis between September 2018 and September 2019 were retrospectively analyzed. Twenty-six distinct MEFV gene mutation variants were studied. Demographic and clinical data of study participants were collected from patient charts and hospital electronic database system. Results Out of 910 referred patients, 350 (38.5%) were found to have a positive FMF mutation. In total, we detected 41 different genotypes and 26 different mutations in MEFV gene. The most common mutation and genotype were M694V and heterozygous M694V, respectively. Two hundred and seventy-six patients (78.9%) had a single mutation. Seventy-four patients had compound heterozygous mutation (21.1%). The most common compound heterozygous mutation was P369S/R408Q (23.3%). Five founder mutations constituted the seventy-five percent of the all mutations detected. Rare mutations that generally not examined in other studies were present in 15 patients (%4.2) in the form of two different compound heterozygous genotype. The total allele frequency of these rare mutations was 5%. Conclusion In this study, we examined an extended panel of MEFV mutations and detected more complex genotypes than most of the previous studies conducted in Turkish patients in the literature.